Orion Pharma

DSE: ORIONPHARM

Pharmaceuticals · Orion Group

Orion Pharma is the listed pharmaceutical arm of the diversified Orion Group, manufacturing human and other pharmaceutical products. The parent group also has interests in power generation, infrastructure, and consumer goods.

Business: Human pharmaceutical formulations and related healthcare products for the domestic market and export. The wider Orion Group spans power, real estate, and consumer sectors, of which the listed pharma company is one component.

Market data

Market capitalisation

5,990 mn BDT

Paid-up capital

2,340 mn BDT

Outstanding shares

234,000,000

Last price

26.1 BDT

Listed

2013

Market category

Z

Source: Dhaka Stock Exchange, fetched 2026-05

Policy exposure

Z-category listing status and investor protection Orion Pharma trades in the DSE Z category, which signals issues such as missed dividends or compliance lapses and flags heightened minority-investor risk for the securities regulator. Source: Dhaka Stock Exchange, fetched 2026-05

Diversified group exposure and cross-sector risk The Orion Group's heavy presence in power and infrastructure, sectors tied to government contracts and tariffs, means group-level financial and policy risk can spill into the listed pharma entity. Source: analysis

Governance and related-party transactions Conglomerate structure raises the standing concern of intra-group lending and related-party dealings that can disadvantage minority shareholders absent strong disclosure enforcement. Source: analysis